To test the method in a diagnostic setting involving cytology preparations, we prepared tumor imprint slides from eight prospective fresh colon cancer specimens with unknown KRAS mutation status, and subjected them to multiplex KRAS in situ mutation detection (Fig. 3C-F, Table 2 and Supplementary Fig. 8). This evidence concerns the gene KRAS and malignant colon neoplasm.